Bulletin 262: Probiotics
This bulletin provides is an update on probiotics. It focuses on reviewing prescribing of probiotics (including VSL#3® and Vivomixx®) and discontinuing therapy in light of the fact probiotic products are no longer approved under the ACBS scheme.
An audit and patient letter are available for organisations considering reviewing this therapy area.
